Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

However, it also highlights some challenges in how doctors and AI work together. The study, published in Nature Communications, focused on AI-assisted radiotherapy for two types of cancer: non-small ...

A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work together. The study ...

Imvax is targeting the same form of brain cancer that claimed the lives of former Phillies pitcher Tug McGraw and catcher ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of Michigan,  shows that artificial intelligence (AI) can help doctors make better ...

Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...